You have 9 free searches left this month | for more free features.

MGN1703

Showing 1 - 8 of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Cancers, Melanoma Trial in Houston (MGN1703, Ipilimumab)

Active, not recruiting
  • Advanced Cancers
  • Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 11, 2022

HIV-1-infection Trial in Worldwide (Saline, Lefitolimod, 3BNC117 and 10-1074)

Active, not recruiting
  • HIV-1-infection
  • Salt Lake City, Utah
  • +7 more
Mar 30, 2022

Small Cell Lung Cancer Trial in Worldwide (MGN1703, Standard of care)

Completed
  • Small Cell Lung Cancer
  • MGN1703
  • Standard of care
  • Innsbruck, Austria
  • +3 more
Nov 13, 2018

Treatment Related Cancer Trial in Munich (5-FU, Folinic Acid, Irinotecan)

Active, not recruiting
  • Treatment Related Cancer
  • Munich, Germany
    Ludwig Maximilians University
Jan 19, 2022

Metastatic Colorectal Cancer Trial in Worldwide (Usual Maintenance, MGN1703 treatment)

Unknown status
  • Metastatic Colorectal Cancer
  • Usual Maintenance
  • MGN1703 treatment
  • Krems, Austria
  • +126 more
Sep 9, 2019

HIV Trial in Aarhus N, Hvidovre (MGN1703)

Completed
  • HIV
  • MGN1703
  • Aarhus N, Denmark
  • +1 more
Jun 28, 2017

Healthy Trial in West Bend (MGN-Placebo, Placebo-MGN)

Completed
  • Healthy
  • MGN-Placebo
  • Placebo-MGN
  • West Bend, Wisconsin
    Spaulding Clinical
May 16, 2014

Advanced Colorectal Carcinoma Trial in Worldwide (MGN1703, Placebo)

Completed
  • Advanced Colorectal Carcinoma
  • MGN1703
  • Placebo
  • Wien, Austria
  • +11 more
Jun 19, 2014